PURPOSE: We sought to identify an anesthetic regime that, unlike isoflurane in air, would maintain glucose homeostasis in mice undergoing Positron emission tomography (PET) imaging with 2-deoxy-2-[18F]fluoro-D: -glucose (FDG). MATERIALS AND METHODS: FDG uptake was also measured in normal and tumor tissues. Athymic and Balb/c nude mice were studied. Blood glucose levels were measured before and after 30 min of FDG PET imaging under isoflurane or sevoflurane carried in air or oxygen. FDG uptake was quantified as a percentage of the injected dose and using Patlak analysis yielding Ki values. RESULTS: Blood glucose levels were more stable under sevoflurane than under isoflurane, especially in the athymic nude mice. Under isoflurane, FDG uptake into myocardium was higher than under sevoflurane and was strongly correlated with the intrascan change in blood glucose. CONCLUSION: Sevoflurane should be preferred for physiologic imaging in mice, minimizing changes in glucose and, for FDG PET, reducing signal spillover from the myocardium.
PURPOSE: We sought to identify an anesthetic regime that, unlike isoflurane in air, would maintain glucose homeostasis in mice undergoing Positron emission tomography (PET) imaging with 2-deoxy-2-[18F]fluoro-D: -glucose (FDG). MATERIALS AND METHODS:FDG uptake was also measured in normal and tumor tissues. Athymic and Balb/c nude mice were studied. Blood glucose levels were measured before and after 30 min of FDG PET imaging under isoflurane or sevoflurane carried in air or oxygen. FDG uptake was quantified as a percentage of the injected dose and using Patlak analysis yielding Ki values. RESULTS:Blood glucose levels were more stable under sevoflurane than under isoflurane, especially in the athymic nude mice. Under isoflurane, FDG uptake into myocardium was higher than under sevoflurane and was strongly correlated with the intrascan change in blood glucose. CONCLUSION:Sevoflurane should be preferred for physiologic imaging in mice, minimizing changes in glucose and, for FDG PET, reducing signal spillover from the myocardium.
Authors: Y Kuge; K Minematsu; Y Hasegawa; T Yamaguchi; H Mori; H Matsuura; N Hashimoto; Y Miyake Journal: J Cereb Blood Flow Metab Date: 1997-01 Impact factor: 6.200
Authors: Barbara J Fueger; Johannes Czernin; Isabel Hildebrandt; Chris Tran; Benjamin S Halpern; David Stout; Michael E Phelps; Wolfgang A Weber Journal: J Nucl Med Date: 2006-06 Impact factor: 10.057
Authors: Linda W Chan; Sebastien Hapdey; Sean English; Jurgen Seidel; Joann Carson; Anastasia L Sowers; Murali C Krishna; Michael V Green; James B Mitchell; Stephen L Bacharach Journal: Radiat Oncol Date: 2006-02-28 Impact factor: 3.481
Authors: Krista Bigiarelli; Luke E Schepers; Arvin H Soepriatna; Dave FitzMiller; Craig J Goergen Journal: J Vis Exp Date: 2020-07-09 Impact factor: 1.355
Authors: Yu Ouyang; Martin S Judenhofer; Jeffrey H Walton; Jan Marik; Simon P Williams; Simon R Cherry Journal: J Vis Exp Date: 2015-09-20 Impact factor: 1.355
Authors: Yinlin Li; Tao Huang; Xinyue Zhang; Min Zhong; Natalie N Walker; Jiang He; Stuart S Berr; Susanna R Keller; Bijoy K Kundu Journal: Mol Imaging Date: 2015 Impact factor: 4.488
Authors: James T Thackeray; Jens P Bankstahl; Yong Wang; Kai C Wollert; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2014-11-12 Impact factor: 9.236
Authors: Jonathan Siikanen; Johanna Sjövall; Anders Forslid; Eva Brun; Maria Bjurberg; Johan Wennerberg; Lars Ekblad; Anders Sandell Journal: Am J Nucl Med Mol Imaging Date: 2015-02-15